EGFR and lung adenocarcinoma: We also found that SD affected various signaling pathways to play a pharmacological role against the growth of lung adenocarcinoma cells, including ERBB2 signaling pathway, epidermal growth factor receptor signaling pathway, and phosphatidylinositol-mediated signaling.